We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Radcal IBA  Group

Download Mobile App




4D Flow MRI Scans Could Revolutionize Diagnosis of Patients with Heart Failure

By HospiMedica International staff writers
Posted on 28 Jun 2022

Researchers have developed cutting-edge imaging technology to help doctors better diagnose and monitor patients with heart failure. More...

The state-of-the-art technology uses magnetic resonance imaging (MRI) to create detailed 4D flow images of the heart. The 4D heart MRI scan takes just six to eight minutes and can provide precise imaging of the heart valves and the flow inside the heart in three-dimension, helping doctors determine the best course of treatment for patients.

A new study by researchers at the University of East Anglia (Norwich, Norfolk, UK) has shown how this non-invasive imaging technique can measure the peak velocity of blood flow in the heart accurately and precisely. The researchers tested the new technology on 50 patients with suspected heart failure who were assessed using both echocardiography and the new advanced 4D flow heart MRI. The researchers developed prototype software to automate the process of measuring the peak velocity of blood flow inside the heart. The team hopes their work could revolutionize how heart failure is diagnosed.

“In our study, we used one of the most cutting-edge methods of flow assessment inside the heart called 4D flow MRI,” said lead researcher Dr. Pankaj Garg, from UEA’s Norwich Medical School. “In 4D flow MRI, we can look at the flow in three directions over time - the fourth dimension. We applied automated methods to hunt for the peak velocity in the chamber of the heart and showed that it is similar to echocardiography assessment, but with much greater precision.”

“This work is very important because the heart’s inability to relax leads to a rise in pressures inside the heart, and this causes heart failure with preserved ejection fraction,” added Dr. Garg. “Peak velocity of the blood flow inside the heart is a very important assessment for patients, and our findings show that by using a state-of-the-art 4D flow MRI imaging, we can do this accurately and with a high degree of repeatability. This advanced imaging offers an alternative to ultrasound methods and may even be better than ultrasound in the future.”

Related Links:
University of East Anglia 


Gold Member
STI Test
Vivalytic Sexually Transmitted Infection (STI) Array
Gold Member
POC Blood Gas Analyzer
Stat Profile Prime Plus
New
Pediatric Cast Saw
CSP-201 Quietcast
New
Pressure Transducer
TruWave
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Surgical Techniques

view channel
Image: The engine-free, nonlinear, flexible, micro-robotic platform leverages AI to optimize GBM treatment (Photo courtesy of Symphony Robotics)

First-Ever MRI-Steerable Micro-Robotics to Revolutionize Glioblastoma Treatment

Glioblastoma Multiforme (GBM) is one of the most aggressive and difficult-to-treat brain cancers. Traditional surgical procedures, such as craniotomies, involve significant invasiveness, requiring large... Read more

Patient Care

view channel
Image: The portable biosensor platform uses printed electrochemical sensors for the rapid, selective detection of Staphylococcus aureus (Photo courtesy of AIMPLAS)

Portable Biosensor Platform to Reduce Hospital-Acquired Infections

Approximately 4 million patients in the European Union acquire healthcare-associated infections (HAIs) or nosocomial infections each year, with around 37,000 deaths directly resulting from these infections,... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.